Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS · Delayed Price · Currency is USD
4.900
+0.050 (1.03%)
At close: Jan 6, 2026
HNSPF Market Cap
HNSPF has a market cap or net worth of $32.31 billion as of January 9, 2026. Its market cap has increased by 138.10% in one year.
Market Cap
32.31B
Enterprise Value
28.51B
Revenue
1.84B
Ranking
n/a
PE Ratio
48.41
Stock Price
$4.90
Market Cap Chart
Since June 14, 2019, HNSPF's market cap has increased from 14.22B to 32.31B, an increase of 127.26%. That is a compound annual growth rate of 13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 32.31B | 15.12% |
| Dec 31, 2025 | 28.06B | 112.57% |
| Dec 31, 2024 | 13.20B | 10.47% |
| Dec 29, 2023 | 11.95B | 6.05% |
| Dec 30, 2022 | 11.27B | -21.91% |
| Dec 31, 2021 | 14.43B | -49.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 711.87M |
| Elite Pharmaceuticals | 521.08M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 260.73M |